Angiocomfort s.r.o.
- Address
- Prostejovská 125, 080 01 Prešov, Slovakia
Angiocomfort s.r.o. - Advanced Wound Healing Research Center
Angiocomfort s.r.o. is a specialized clinical research facility dedicated to advancing treatment options for patients with complex vascular conditions and chronic wound healing disorders. The center focuses on evaluating innovative regenerative medicine approaches for conditions that have proven resistant to conventional therapeutic interventions.
- Stem cell therapy for chronic venous ulcers
- Regenerative medicine applications in wound healing
- Treatment of therapy-resistant vascular leg ulcers
The center's research program emphasizes chronic venous ulcers (CVU), particularly those classified as long-term, non-healing wounds that have not responded to standard treatment protocols. Through rigorous clinical investigation, Angiocomfort evaluates novel allogeneic stem cell therapies administered topically, assessing both efficacy through complete wound closure monitoring and comprehensive safety profiles. This work represents a significant contribution to addressing the substantial unmet medical need in patients suffering from therapy-resistant venous leg ulcers.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Angiocomfort s.r.o.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Allogeneic Skin-Derived ABCB5-Positive Dermal Mesenchymal Stromal Cells in Therapy-Resistant Chronic Venous Ulcers | Rheacell GmbH & Co. KG | Phase III | Not Recruiting | Jan 2025 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Allogeneic Skin-Derived Abcb5-Positive Dermal Mesenchymal Stromal Cells | 1 | Unknown | 2025-01-16 | 2025-01-16 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.